利用人类微生物群来向细菌呼吸道病原体:通往扩大抗微生物武器库的新途径
Jillian H Hurst1,2, Matthew S Kelly1,2
1Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine , Durham, North Carolina, USA.
研究人员发现,Rothia细菌可以抑制Moraxella catarrhalis的生长,这是一个常见的呼吸道病原体. 这一发现为开发对抗抗生素耐药细菌的治疗提供了潜在的新途径.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 急性呼吸道感染是全球儿童死亡的主要原因.
- 抗生素耐药性是一个日益增长的威胁,很少有新药在开发中.
- 微生物天然产品是当前抗生素的主要来源.
研究的目的:
- 为了确定抗菌化合物的新型微生物来源.
- 研究呼吸道微生物群作为生物治疗药物的来源的潜力.
- 探索抗生素耐药性呼吸道病原体的新策略.
主要方法:
- 选Rothia物种针对Moraxella catarrhalis的抗菌活性.
- 在体外和体外测试以确认增长抑制.
- 对抗微生物活性负责的分泌因子的分析,包括甘氨酸内酶.
主要成果:
- 罗提亚物种在体外和体外显著抑制了Moraxella catarrhalis的生长.
- 一种由Rothia分泌的新型酸甘氨酸内酶被确定为这种活动的关键因素.
- 鉴定到的酶向的是Moraxella catarrhalis的细胞壁.
结论:
- 人的呼吸道微生物群含有潜在的生物治疗剂.
- 罗西亚物种及其分泌的酶是新型抗菌药物发现的有希望的来源.
- 这些发现有助于迫切需要新的抗抗菌素耐药性治疗方法.
更多相关视频
11:23Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
相关概念视频
Microorganisms in Medicine and Therapeutics
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
